Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 94Neoplasm Metastasis 6Breast Diseases 3Prostatic Neoplasms 2Ovarian Neoplasms 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Triple Negative Breast Neoplasms 1Recurrence 1Primary Breast Cancer ER+ve 1Pancreatic Neoplasms 1Neoplasms 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Multiple Endocrine Neoplasia Type 1 1Metastatic Beast Cancer 1Mammary Neoplasms, Animal 1Locoregional Recurrence 1Lethal Congenital Contracture Syndrome 2 1Hyperglycemia 1Hormone Receptor Positive Malignant Neoplasm of Breast 1HER2-positive Breast Cancer 1Granulosa cell tumor of the ovary 1Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1Endometrial Stromal Tumors 1Endometrial Hyperplasia 1ER+ Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Paclitaxel 34Carboplatin 27pembrolizumab 20Bevacizumab 16Letrozole 13Megestrol Acetate 10Cisplatin 9lenvatinib 8olaparib 7dostarlimab 7Metformin 7durvalumab 6abemaciclib 6Radiotherapy 6Everolimus 6niraparib 5Specimen Handling 5Nivolumab 5Medroxyprogesterone Acetate 5Magnetic Resonance Spectroscopy 5Gemcitabine 5Fluorouracil 5Docetaxel 5Biopsy 5temsirolimus 4rucaparib 4Oxaliplatin 4Fulvestrant 4Doxorubicin 4sapanisertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Endometrial Neoplasms × exemestane × Clear all
NCT03300557 2025-08-29

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled 13 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01965080 2013-10-18

Exemestane in Advanced and Recurrent Endometrial Carcinoma

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Completed
52 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡